Antiarrhythmic Drugs
Springer International Publishing (Verlag)
978-3-031-74045-9 (ISBN)
- Noch nicht erschienen - erscheint am 13.01.2025
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
This extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment.
Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
A Martinez Rubio, is Chief of the Cardiology Department at the University Hospital of Sabadell and professor of Medicine at the Universitat Autònoma of Barcelona, Spain. Ex-president of the International Society of Cardiovascular Pharmacotherapy
J Tamargo is professor of Pharmacology at the School of Medicine of the Univ. Complutense of Madrid, Spain
G.-Andrei Dan is Distinguished/Emeritus Professor of Cardiology & Internal Medicine at the Carol Davila University of Medicine, Honorary Member of the Romanian Academy of Scientists and past President of ISCP. Profesor Dan' main expertise is electrophysiology, pharmacology of antiarrhythmic drugs, atrial fibrillation and heart failure. He wrote more than 170 scientific papers, presented more than 50 international conferences and contributed to 15 European guidelines. He is a member of the board of several prestigious medical journals, Deputy Editor of the American Journal of Therapeutics and Editor in Chief of the Romanian Journal of Internal Medicine. He is also an Honorary Citizen of the Romanian capital, Bucharest
Introduction: Cardiac arrhythmias a clinical problem.- Electrophysiological basis of the arrhythmias.- Class I antiarrhythmic drugs (Na+ channel blockers).- Potassium-channel blockers.- Betablockers.- Modulation of calcium handling/Calcium-channel modulators.- Other antiarrhythmic drugs: Novel targets for AADs.- Non-antiarrhythmic drugs with antiarrhythmic effects.- Clinical management of the arrhythmias.
| Erscheint lt. Verlag | 13.1.2025 |
|---|---|
| Zusatzinfo | XVI, 525 p. 132 illus., 102 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Schlagworte | Antiarrhythmic Drugs • Arrhythmias • Atrial Fibrillation • bradycardia • pharmacotherapy • Supraventricular tachycardia • ventricular Tachycardia |
| ISBN-10 | 3-031-74045-9 / 3031740459 |
| ISBN-13 | 978-3-031-74045-9 / 9783031740459 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
